NPPB and hydrops fetalis: The participants who received empagliflozin showed a reduction in the combined incidence of worsening HF, rehospitalization for HF, or death at 60 days; however, they failed to reach these end points separately, as well as diuretic response, NT‐proBNP, and some other parameters (11).